Tigermed

Forecast & Rating14 analysts currently cover Tigermed, with about 71.4% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥62.28, about 12.2% upside from the current price of ¥55.52. Price targets range from ¥42.00 to ¥78.00 — a wide spread, showing clear disagreement over just how much Tigermed can rise. Historically, about 39.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Tigermed closely still see room for the stock to rise. Data as of Aug 19, 2026; for reference only and not investment advice.